Annexin-l (also called lipocortin-1 or p35), a putative substrate of the epidermal growth factor/receptor kinase, protein kinase C, and trans glutaminase, was immunolocalized in embryonic, neonatal, adult, and diseased human epidermis. In embryonic skin intense annexin-l immunoreactivity was found in the periderm at 54 d estimated gestational age (EGA). Later (EGA = 91-143 d), annexin-1 immunoreactivity was restricted to basal keratinocytes. In neonatal skin, basal cells were often more heavily stained than were suprabasal keratinocytes, which were also stained. Only basal keratinocytes stained in adult plantar skin, but in thin skin annexin-l was present in the basal, suprabasal, and sometimes A nneXin_l, originally isolated from A431 carcinoma cells and termed p35, was first described as a substrate of the epidermal growth factor (EGF) receptor tyrosine-kinase [1, 2] . It now is known to be present in many cell types, including cell s that lack the EGF receptor (macrophages, neutrophils) [3] . Annexin-1 is one of a family of re lated calcium-and 'phospholipid-binding proteins previously termed the calpactins [4] or the lipocortins (5J and presently call ed the annexins. Although the annexins are well characterized biochemically, the specific biologic functions of several of the annexins are unclear. Reports of anti-inflammatory properties [6] [7] [8] [9] [10] [11] , effects on keratinocyte differentiation [12] , and links to exocytic events [13 -18] have been made for certain annexins.
Annexin-l (also called lipocortin-1 or p35), a putative substrate of the epidermal growth factor/receptor kinase, protein kinase C, and trans glutaminase, was immunolocalized in embryonic, neonatal, adult, and diseased human epidermis. In embryonic skin intense annexin-l immunoreactivity was found in the periderm at 54 d estimated gestational age (EGA). Later (EGA = 91-143 d), annexin-1 immunoreactivity was restricted to basal keratinocytes. In neonatal skin, basal cells were often more heavily stained than were suprabasal keratinocytes, which were also stained. Only basal keratinocytes stained in adult plantar skin, but in thin skin annexin-l was present in the basal, suprabasal, and sometimes A nneXin_l, originally isolated from A431 carcinoma cells and termed p35, was first described as a substrate of the epidermal growth factor (EGF) receptor tyrosine-kinase [1, 2] . It now is known to be present in many cell types, including cell s that lack the EGF receptor (macrophages, neutrophils) [3] . Annexin-1 is one of a family of re lated calcium-and 'phospholipid-binding proteins previously termed the calpactins [4] or the lipocortins (5J and presently call ed the annexins. Although the annexins are well characterized biochemically, the specific biologic functions of several of the annexins are unclear. Reports of anti-inflammatory properties [6] [7] [8] [9] [10] [11] , effects on keratinocyte differentiation [12] , and links to exocytic events [13 -18] have been made for certain annexins.
Here, we llsed polyclonal antisera of high affinity and specificity for annexill-l [1, 3, 19] to determine the pattern of its immunoreactivity in embryonic, normal, and diseased human skin. We observed changing patterns of annexin-l among the epidermal components of embryonic human skin and also in a variety of abnormal skin lesions. A striking pattern of immunoreactivity that suggests association of annexin-l w ith cell membranes/tonofilaments/desmo-even in the granular layers of the epidermis. Often, annexin-1 appeared concentrated around the perimeter of cells, especially tonofilament/ desmosome-rich keratinocytes of the spinous-cell layer. At high magnification, annexin-l appeared associated with distinct structures and was very granular in appearance in the intensely stained ductal keratinocytes of eccrine sweat glands, cells that are very highly enriched in keratin tOl1ofilaments. This striking distribution in certain keratinocytes enriched in tonofilaments suggests a role for annexin-1 in cytoskeletal functions. Key words: annexin-l/stratum spinosum/keratinocytes. J [I/vest D ermatol 101 : [732] [733] [734] [735] [736] [737] 1993 specimens and may offer a due to its biologic function in keratinocytes.
MATERIALS AND METHODS
Antibodies and Immunologic Reagents A polyclonal antiserum of broad species crossreactivity was prepared in rabbit against annexin-l isolated from human A431 cells [1, 19] . Recombinant human lipocortin-1 (anncxin-l), and an antiserum against p36 were provided by Blake Pepinsky, Biogen Inc., Cambridge, MA. A monospecific antiserum directed against a synthetic peptide corresponding to a portion of the N-terminus of human lipocortin-1 was provided by Andrew Kraft, Birmingham, AL. Immunolocalization was performed using a Vectastain av idin biotin peroxidase compl ex (ABC) kit purchased from Vector Laboratories, Burlingame, CA. 3,3' -diaminobenzidine tetrahydrochlotide (DAB) was from Sigma, St. Louis, MO.
Acquisition of Tissue Specimens All biopsies were obtained according to Depattment of Health, Education and Welfare guidelines and with the approval of the University of Washington and Vanderbilt University Human Subjects Review Board. Embryonic skin specimens representing 54-147 d gestation were from the Central Laboratory for Human Embryology at the University of Washington through the courtesy of Karen Holbrook, Ph.D. Fetal samples were coll ected in steri le sa line and transferred to Carnoy's fix ative within 2-6 h. Neonatal samples were obtained from the newborn nursery at Vanderbilt University Medical Center and Dartmouth Med ical School and were processed immediately. Adult skin specimens were fixed immediately upon co llection . The following hyperproliferative skin diseases were also examined: psoriasis vu lgaris (n = 5), seborrheic keratosis (n = 2), s'luamous ce ll carcinoma (n = 2), keratoacanthoma (n = 1), and ruptured epidermal cyst (n = 1). nons pecific staining [3J. With Carnoy's fix ed tissue, the polyclona l annexi n-l antiserum ex hibited stainin g from 1/500 to 1/ 10,000 dilu tion.
Preparation of Tissue Specimens
Irnrnunolocalization Protocol Sections were sta in ed exactly as described previousl y [3J . Several controls were used to estab lish the specificity of sta ining . A fivefold lower di luti on of pooled normal rabbit serum and a twofo ld lower dilution of preimmune serum were used to identify artifactual or nonspecific sra inin g. Al so the primary antiserum was preincubated with
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purified antigen before use in th e stai nin g protocol. Specifica ll y, aliquots of the primary antisemm diluted 1 : 2000 with phosphate-buffered saline (PBS) containin g 1 % normal goat serum and 10 mM ethyleneglycol-bis(Paminoeth yl ether)-N,N,N',N '-tetraacetic ac id (EGTA) were incubated at 4· C for 12 -16 h with increasing amounts of anncxin-l. Gradual disappearance of stainin g was observed as the co nce ntration of ann ex in-l was increased from 1 to 100 fig/ m!' Finall y, the staining pattern observed in human and so mc rat tissues was confirmed by co mpariso n to that obtained with a peptide-directed anti serum against annexin-l . Western Blotting of Neonatal Epidermal Keratinocyte Proteins NCOI1<1tal foreskin spec imens were processed within 30 min of acquisition. After incubation for 30 min in 1 M NaBr with 20 mMEGTA at 4°C and an additional 45 min at 37"C, th e epidermis was separated with forceps from the dermis as a sin gle sheet of cells. The epidermal cells were washed in PBS and ce ntrifu ged, and proteins were solubilized by addition of an equal volume of SDS-polyacryl amide gel electrophoresis (PAGE) sample buffer. SDS-PAGE was throu gh a 10% gel and a replicate gel was blotted onto nitroce llulose. A standard of pure recombinant annexin-1 (150 ng), an amount chosen to be appropriate for the W estern blot, was included with eac h gel. The antiserum versus annexin-1 used in this study was used at 1: 2000 dillltion and developed with a Vector Labs ABC kit followll1g the manufacturer's instructions.
RESULTS
Normal Developing Human Skin I-Iuman embryonic skin specimens taken from embryos of estimated gestational age (EGA) of 55, 81,93,105, and 143 d were examined by immunostaining for annexin-I. As shown in Fig 1, an interesting progression in the sites o f annexin-I immunoreactivity was observed, which changed as a fun ction of stage of development and epidermal stratification. The most superficial aspect of the early periderm was one of the most intensely stained sites (even compared to all tissues examined to date [3] ), shown in Fig 1a. Large blebbing surface structures contained immunoreactive m aterial as well.
Annexin-I was detected in both the basal cells and the outer periderm during the embryonic stage, EGA 42-56, when a two- -81 ), annexin-l was d~tected in.all three layers (Fig la) . In areas of follIcular morphogeneSIs, annexll1-1 was present in keratinocytes associated with developing follicles. As the interfollicular epidermis became more differentiated, annexin-1 became restricted to basal keratinocytes (Fig Ie) . Interestingly, in the neonatal period (shown in Fig 2c) , the distribution of annexin-l was once again throughout all nucleated cell layers of the epidermis.
Normal Adult Human Epidermis and Appendages The distribution of annexin-I in epidermis was varied depending on the type of skin specimen examined (thickness, age of donor); however, an enrichment and in some cases a strict restriction of immunoreactivity to the least differentiated basal keratinocytes was observed, especially in thick skin. As shown in Fig 2 a,d , strict basal keratinocyte staining was most dramatic in thick plantar skin. A similar pattern of basal cell predominance was also seen in neonatal foreskin, although expression of annexin-l into the suprabasal cell layer was also seen (Fig 2c) . At high magnification in some cases, annexin-1 was concentrated in the cortical cytoplasm of the basal keratinocytes, as shown in Fig 2d (arrow) . Dermal fibroblasts in intrafollicular regions also stained positively.
Several cell types in skin appendages stained positively for an. -nexin-l. Of particular interest were extremely high levels of stain- epidermis was found to be very sensitive to ?egradation by proteases and in several specimens that were not obtallled or processed Immediately after collection, multiple, lower-molecular-weight immunoreactive degradation products were seen. Also, proteolytic sepamien of the epidermis from dermis with trypsin invariably caused degradation of annexin-l, as did inadequate chelation of calcium v.lth EGTA when 1 M NaBr was used, demonstrating a sensitivity 10 degradation by calcium-activated proteases. Concentration of Annexin-l in Intercellular Processes of Spinous Cells A cortical cytoplasmic staining pattern of annexin-l was seen in portions of many of the normal and diseased skin specimens examined (data not shown). An extraordinary example observed in a thick skin specimen is shown in Fig 4. Figure 4b illustrates annexin-l staining in the expanded spinous layer of this specimen, a portion of which is shown at very high magnification (-1000 X) in Fig 4c. Annexin-1 immunoreactivity was found almost entirely around the perimeter of the cells and appeared highly concentrated in the tonofilament/ desmosome-rich intercellular processes that are a unique feature of the spinous cell layer. Both transverse and cross-sectional orientations of these processes are seen in the figure. Annexin-l immunoreactivity appears as dots where the plane of section was cross-sectional through these processes (see arrows in Fig 4,) , and otherwise appears linear. Whereas this specimen offered a most spectacular example, this phenomenon was not uncommon (data not shown). It was also interesting that ductal epithelium of eccrine sweat glands, which are highly enriched in tonofilaments [20] , had intense annexin-l staining of a granular nature that was apparent throughout cells of the epitheliUln, but was impossible to illustrate in a single photographic plane of focus (data not shown).
DISCUSSION
In this study, we compared the pattern of annexin-l protein in normal skin and appendages to that seen during human embryogenesis. We found that annexin-l does not strictly correlate with the EGF-receptor distribution in skin [21, 22] , as was also seen in other organs in previous studies, which shows that, despite its capacity to be phosphorylated by the EGF receptor kinase, annexin-l is likely to function primarily in EGF-independent pathways [3] .
As several annexins are found in keratinocytes, specificity of the staining patterns for annexin-l was carefully addressed. Ablation of staining by preincubation of antibody with pure annexin-1 was performed, as well as confirmation of staining patterns with an antiserum made against an N-terminal peptide sequence unique to ·annexin-l [23] . Western blot analysis indicated only one 35-kDa immunoreactive band in protein extracts of epidermal keratinocytes. We also observed no immunoreactivity in a Western blotting analysis of pure annexin-3, the most closely related annexin (data not shown). We do not. know whether the two antisera used in this study recognize the conformation-specific epitope of annexin-l, which is presented only after calcium binding [24] .
Annexin-l has been implicated in cornified envelope formation [25] , is a substrate of transglutaminase [26, 27] , and has been found crosslinked to involucrin in vitro (28] . If annexin-l does participate in the transition of keratinocytes to corneocytes in vivo, it may be that in thick plantar skin, annexin-l was absent from suprabasal cells because it was degraded before the keratinocytes had risen in the epidermal layer, a process that occurs very slowly in this specialized type of epidermis. In contrast, in psoriasis, where hyperproliferation rapidly drives cells upward in the epidermis, annexin-l remains present in cells in upper layers ( [29] and data not shown). 1/1 situ hybridization studies may more precisely identify sites of annexin-1 sy nthesis in Ilivo.
A definitive demonstration of the biologic function(s) of annexin-l in skin has so far evaded the efforts of many investigators. Violette et a/showed with purified annexin-l and specific monoclonal antibodies that annexin-1 may be involved in I;'romoting the differentiation of squamous carcinoma cells i'l vitro [12] . They described a pathway involving arachidonic acid and phospholipase A2 that is antagonized by EGF and suggests a connection between EGF, annexin-1, and squamous cell differentiation [12] . Studies from other laboratories described an annexin-l association with plasma membrane in vivo that suggest it may be in a other associated structures may be a clue to its function in vivo . T hr annexin-l distribution shown in this report aligned very well with both transverse and cross-sectional views through intercellular processes that are unusually rich in tonofilaments and desmosomes structures that create the appearance of the "prickle" cells of th; stratum spinosum . . This rattern o~ annexi n-1 immunoreactivity suggests the posslbthty 0 an association of annexin-l with some component of this structural complex, possibly tonofilaments. The extremelx high level of anne~in-l noted in eccrine sweat duct epithelIUm IS consistent WIth thiS notion, as these ductal keratinocytes are so highly enriched in desmosomes and to no filaments that the. . often appear hyalinized [20] . Further biochemical studies and studies of annexi n-1 localization at the ultrastructural level will be required to determine whether or not there is a specific association of annexin-l with structural components in keratinocytes that is of functional significance. 
